David Malcom Rodman - Chief Medical Officer at Mineralys Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer
Issuer Symbol
MLYS on Nasdaq
All Insider Reports
All Insider Reports

David Malcom Rodman - trading volume in the past year for Mineralys Therapeutics, Inc.

Holdings reported by David Malcom Rodman for Mineralys Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 44,089 $1,216,128 $27.58 13 Feb 2026 Direct
Stock Option 100,001 13 Feb 2026 Direct Common Stock

Transactions reported by David Malcom Rodman for Mineralys Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.